Skip to main content
Top
Published in: BMC Cancer 1/2020

Open Access 01-12-2020 | Research article

The initial engraftment of tumor cells is critical for the future growth pattern: a mathematical study based on simulations and animal experiments

Authors: Bertin Hoffmann, Tobias Lange, Vera Labitzky, Kristoffer Riecken, Andreas Wree, Udo Schumacher, Gero Wedemann

Published in: BMC Cancer | Issue 1/2020

Login to get access

Abstract

Background

Xenograft mouse tumor models are used to study mechanisms of tumor growth and metastasis formation and to investigate the efficacy of different therapeutic interventions. After injection the engrafted cells form a local tumor nodule. Following an initial lag period of several days, the size of the tumor is measured periodically throughout the experiment using calipers. This method of determining tumor size is error prone because the measurement is two-dimensional (calipers do not measure tumor depth). Primary tumor growth can be described mathematically by suitable growth functions, the choice of which is not always obvious. Growth parameters provide information on tumor growth and are determined by applying nonlinear curve fitting.

Methods

We used self-generated synthetic data including random measurement errors to research the accuracy of parameter estimation based on caliper measured tumor data. Fit metrics were investigated to identify the most appropriate growth function for a given synthetic dataset. We studied the effects of measuring tumor size at different frequencies on the accuracy and precision of the estimated parameters. For curve fitting with fixed initial tumor volume, we varied this fixed initial volume during the fitting process to investigate the effect on the resulting estimated parameters. We determined the number of surviving engrafted tumor cells after injection using ex vivo bioluminescence imaging, to demonstrate the effect on experiments of incorrect assumptions about the initial tumor volume.

Results

To select a suitable growth function, measurement data from at least 15 animals should be considered. Tumor volume should be measured at least every three days to estimate accurate growth parameters. Daily measurement of the tumor volume is the most accurate way to improve long-term predictability of tumor growth. The initial tumor volume needs to have a fixed value in order to achieve meaningful results. An incorrect value for the initial tumor volume leads to large deviations in the resulting growth parameters.

Conclusions

The actual number of cancer cells engrafting directly after subcutaneous injection is critical for future tumor growth and distinctly influences the parameters for tumor growth determined by curve fitting.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ireson CR, Alavijeh MS, Palmer AM, Fowler ER, Jones HJ. The role of mouse tumour models in the discovery and development of anticancer drugs. Br J Cancer. 2019;121:101–8.CrossRef Ireson CR, Alavijeh MS, Palmer AM, Fowler ER, Jones HJ. The role of mouse tumour models in the discovery and development of anticancer drugs. Br J Cancer. 2019;121:101–8.CrossRef
3.
go back to reference Jin H, Yang R, Ross J, Fong S, Carano R, Totpal K, et al. Cooperation of the agonistic DR5 antibody apomab with chemotherapy to inhibit orthotopic lung tumor growth and improve survival. Clin Cancer Res. 2008;14:7733–40.CrossRef Jin H, Yang R, Ross J, Fong S, Carano R, Totpal K, et al. Cooperation of the agonistic DR5 antibody apomab with chemotherapy to inhibit orthotopic lung tumor growth and improve survival. Clin Cancer Res. 2008;14:7733–40.CrossRef
4.
go back to reference Liebman MA, Roche MI, Williams BR, Kim J, Pageau SC, Sharon J. Antibody treatment of human tumor xenografts elicits active anti-tumor immunity in nude mice. Immunol Lett. 2007;114:16–22.CrossRef Liebman MA, Roche MI, Williams BR, Kim J, Pageau SC, Sharon J. Antibody treatment of human tumor xenografts elicits active anti-tumor immunity in nude mice. Immunol Lett. 2007;114:16–22.CrossRef
5.
go back to reference Warburton C, Dragowska WH, Gelmon K, Chia S, Yan H, Masin D, et al. Treatment of HER-2/neu overexpressing breast Cancer Xenograft models with Trastuzumab (Herceptin) and Gefitinib (ZD1839): drug combination effects on tumor growth, HER-2/neu and epidermal growth factor receptor expression, and viable hypoxic cell fraction. Clin Cancer Res. 2004;10:2512–24.CrossRef Warburton C, Dragowska WH, Gelmon K, Chia S, Yan H, Masin D, et al. Treatment of HER-2/neu overexpressing breast Cancer Xenograft models with Trastuzumab (Herceptin) and Gefitinib (ZD1839): drug combination effects on tumor growth, HER-2/neu and epidermal growth factor receptor expression, and viable hypoxic cell fraction. Clin Cancer Res. 2004;10:2512–24.CrossRef
6.
go back to reference Davies C de L, Lundstrøm LM, Frengen J, Eikenes L, Bruland ØS, Kaalhus O, et al. Radiation improves the distribution and uptake of liposomal doxorubicin (Caelyx) in human osteosarcoma Xenografts. Cancer Res 2004;64:547–553. Davies C de L, Lundstrøm LM, Frengen J, Eikenes L, Bruland ØS, Kaalhus O, et al. Radiation improves the distribution and uptake of liposomal doxorubicin (Caelyx) in human osteosarcoma Xenografts. Cancer Res 2004;64:547–553.
7.
go back to reference Frenzel T, Hoffmann B, Schmitz R, Bethge A, Schumacher U, Wedemann G. Radiotherapy and chemotherapy change vessel tree geometry and metastatic spread in a small cell lung cancer xenograft mouse tumor model. PLoS One. 2017;12:e0187144.CrossRef Frenzel T, Hoffmann B, Schmitz R, Bethge A, Schumacher U, Wedemann G. Radiotherapy and chemotherapy change vessel tree geometry and metastatic spread in a small cell lung cancer xenograft mouse tumor model. PLoS One. 2017;12:e0187144.CrossRef
8.
go back to reference González MM, Joa JAG, Cabrales LEB, Pupo AEB, Schneider B, Kondakci S, et al. Is cancer a pure growth curve or does it follow a kinetics of dynamical structural transformation? BMC Cancer. 2017;17:174.CrossRef González MM, Joa JAG, Cabrales LEB, Pupo AEB, Schneider B, Kondakci S, et al. Is cancer a pure growth curve or does it follow a kinetics of dynamical structural transformation? BMC Cancer. 2017;17:174.CrossRef
9.
go back to reference Rofstad EK, Fodstad Ø, Lindmo T. Growth characteristics of human melanoma xenografts. Cell Prolif. 1982;15:545–54.CrossRef Rofstad EK, Fodstad Ø, Lindmo T. Growth characteristics of human melanoma xenografts. Cell Prolif. 1982;15:545–54.CrossRef
10.
go back to reference Brodbeck T, Nehmann N, Bethge A, Wedemann G, Schumacher U. Perforin-dependent direct cytotoxicity in natural killer cells induces considerable knockdown of spontaneous lung metastases and computer modelling-proven tumor cell dormancy in a HT29 human colon cancer xenograft mouse model. Mol Cancer. 2014;13:244.CrossRef Brodbeck T, Nehmann N, Bethge A, Wedemann G, Schumacher U. Perforin-dependent direct cytotoxicity in natural killer cells induces considerable knockdown of spontaneous lung metastases and computer modelling-proven tumor cell dormancy in a HT29 human colon cancer xenograft mouse model. Mol Cancer. 2014;13:244.CrossRef
11.
go back to reference Katoh M, Feldhaus S, Schnitzer T, Bauer S, Schumacher U. Limited tumor growth (HT29) in vivo under RO205-2349 is due to increased apoptosis and reduced cell volume but not to decreased proliferation rate. Cancer Lett. 2004;210:7–15.CrossRef Katoh M, Feldhaus S, Schnitzer T, Bauer S, Schumacher U. Limited tumor growth (HT29) in vivo under RO205-2349 is due to increased apoptosis and reduced cell volume but not to decreased proliferation rate. Cancer Lett. 2004;210:7–15.CrossRef
12.
go back to reference Akanuma A. Parameter analysis of Gompertzian function growth model in clinical tumors. Eur J Cancer. 1978;14:681–8.CrossRef Akanuma A. Parameter analysis of Gompertzian function growth model in clinical tumors. Eur J Cancer. 1978;14:681–8.CrossRef
13.
14.
go back to reference Vaidya VG, Alexandro FJ. Evaluation of some mathematical models for tumor growth. Int J Biomed Comput. 1982;13:19–35.CrossRef Vaidya VG, Alexandro FJ. Evaluation of some mathematical models for tumor growth. Int J Biomed Comput. 1982;13:19–35.CrossRef
15.
go back to reference Iwata K, Kawasaki K, Shigesada N. A dynamical model for the growth and size distribution of multiple metastatic tumors. J Theor Biol. 2000;203:177–86.CrossRef Iwata K, Kawasaki K, Shigesada N. A dynamical model for the growth and size distribution of multiple metastatic tumors. J Theor Biol. 2000;203:177–86.CrossRef
16.
go back to reference Wedemann G, Bethge A, Haustein V, Schumacher U. Computer simulation of the metastatic progression. In: Metastasis research protocols. 2nd ed. New York: Springer; 2014. p. 107–16.CrossRef Wedemann G, Bethge A, Haustein V, Schumacher U. Computer simulation of the metastatic progression. In: Metastasis research protocols. 2nd ed. New York: Springer; 2014. p. 107–16.CrossRef
17.
19.
go back to reference Michelson S, Glicksman AS, Leith JT. Growth in solid heterogeneous human colon adenocarcinomas: comparison of simple logistical models. Cell Tissue Kinet. 1987;20:343–55.PubMed Michelson S, Glicksman AS, Leith JT. Growth in solid heterogeneous human colon adenocarcinomas: comparison of simple logistical models. Cell Tissue Kinet. 1987;20:343–55.PubMed
20.
go back to reference Collins VP, Loeffler RK, Tivey H. Observations on growth rates of human tumors. Am J Roentgenol Radium Therapy, Nucl Med. 1956;76:988–1000. Collins VP, Loeffler RK, Tivey H. Observations on growth rates of human tumors. Am J Roentgenol Radium Therapy, Nucl Med. 1956;76:988–1000.
21.
go back to reference Benzekry S, Lamont C, Beheshti A, Tracz A, Ebos JML, Hlatky L, et al. Classical mathematical models for description and prediction of experimental tumor growth. PLoS Comput Biol. 2014;10:e1003800.CrossRef Benzekry S, Lamont C, Beheshti A, Tracz A, Ebos JML, Hlatky L, et al. Classical mathematical models for description and prediction of experimental tumor growth. PLoS Comput Biol. 2014;10:e1003800.CrossRef
22.
go back to reference Sarapata EA, de Pillis LG. A comparison and catalog of intrinsic tumor growth models. Bull Math Biol. 2014;76:2010–24.CrossRef Sarapata EA, de Pillis LG. A comparison and catalog of intrinsic tumor growth models. Bull Math Biol. 2014;76:2010–24.CrossRef
23.
go back to reference von Bertalanffy L. Quantitative Laws in metabolism and growth. Q Rev Biol. 1957;32:217–31.CrossRef von Bertalanffy L. Quantitative Laws in metabolism and growth. Q Rev Biol. 1957;32:217–31.CrossRef
24.
go back to reference Spratt JA, von Fournier D, Spratt JS, Weber EE. Decelerating growth and human breast cancer. Cancer. 1993;71:2013–9.CrossRef Spratt JA, von Fournier D, Spratt JS, Weber EE. Decelerating growth and human breast cancer. Cancer. 1993;71:2013–9.CrossRef
25.
go back to reference Ribba B, Watkin E, Tod M, Girard P, Grenier E, You B, et al. A model of vascular tumour growth in mice combining longitudinal tumour size data with histological biomarkers. Eur J Cancer. 2011;47:479–90.CrossRef Ribba B, Watkin E, Tod M, Girard P, Grenier E, You B, et al. A model of vascular tumour growth in mice combining longitudinal tumour size data with histological biomarkers. Eur J Cancer. 2011;47:479–90.CrossRef
26.
go back to reference Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, et al. Guidelines for the welfare and use of animals in cancer research. Br J Cancer. 2010;102:1555–77.CrossRef Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, et al. Guidelines for the welfare and use of animals in cancer research. Br J Cancer. 2010;102:1555–77.CrossRef
27.
go back to reference Marušić M, Bajzer ſeljko, Vuk-Pavlovic S, Freyer JP Tumor growth in vivo and as multicellular spheroids compared by mathematical models Bull Math Biol 1994;56:617–631. Marušić M, Bajzer ſeljko, Vuk-Pavlovic S, Freyer JP Tumor growth in vivo and as multicellular spheroids compared by mathematical models Bull Math Biol 1994;56:617–631.
32.
go back to reference Hoffmann B, Frenzel T, Schmitz R, Schumacher U, Wedemann G. Modeling growth of tumors and their spreading behavior using mathematical functions. Methods Mol Biol. 1878;2019:263–77. Hoffmann B, Frenzel T, Schmitz R, Schumacher U, Wedemann G. Modeling growth of tumors and their spreading behavior using mathematical functions. Methods Mol Biol. 1878;2019:263–77.
33.
go back to reference Weber K, Thomaschewski M, Warlich M, Volz T, Cornils K, Niebuhr B, et al. RGB marking facilitates multicolor clonal cell tracking. Nat Med. 2011;17:504–9.CrossRef Weber K, Thomaschewski M, Warlich M, Volz T, Cornils K, Niebuhr B, et al. RGB marking facilitates multicolor clonal cell tracking. Nat Med. 2011;17:504–9.CrossRef
34.
go back to reference Murphy H, Jaafari H, Dobrovolny HM. Differences in predictions of ODE models of tumor growth: a cautionary example. BMC Cancer. 2016;16:163.CrossRef Murphy H, Jaafari H, Dobrovolny HM. Differences in predictions of ODE models of tumor growth: a cautionary example. BMC Cancer. 2016;16:163.CrossRef
35.
go back to reference Talkington A, Durrett R. Estimating tumor growth rates in vivo. Bull Math Biol. 2015;77:1934–54.CrossRef Talkington A, Durrett R. Estimating tumor growth rates in vivo. Bull Math Biol. 2015;77:1934–54.CrossRef
36.
go back to reference West J, Newton PK. Cellular interactions constrain tumor growth. PNAS. 2019;116:1918–23.CrossRef West J, Newton PK. Cellular interactions constrain tumor growth. PNAS. 2019;116:1918–23.CrossRef
37.
go back to reference Hart D, Shochat E, Agur Z. The growth law of primary breast cancer as inferred from mammography screening trials data. Br J Cancer. 1998;78:382–7.CrossRef Hart D, Shochat E, Agur Z. The growth law of primary breast cancer as inferred from mammography screening trials data. Br J Cancer. 1998;78:382–7.CrossRef
38.
go back to reference Lange T, Nentwich MF, Lüth M, Yekebas E, Schumacher U. Trastuzumab has anti-metastatic and anti-angiogenic activity in a spontaneous metastasis xenograft model of esophageal adenocarcinoma. Cancer Lett. 2011;308:54–61.CrossRef Lange T, Nentwich MF, Lüth M, Yekebas E, Schumacher U. Trastuzumab has anti-metastatic and anti-angiogenic activity in a spontaneous metastasis xenograft model of esophageal adenocarcinoma. Cancer Lett. 2011;308:54–61.CrossRef
39.
go back to reference Chignola R, Foroni RI. Estimating the growth kinetics of experimental tumors from as few as two determinations of tumor size: implications for clinical oncology. IEEE Trans Biomed Eng. 2005;52:808–15.CrossRef Chignola R, Foroni RI. Estimating the growth kinetics of experimental tumors from as few as two determinations of tumor size: implications for clinical oncology. IEEE Trans Biomed Eng. 2005;52:808–15.CrossRef
41.
go back to reference Motulsky H, Christopoulos A. Fitting models to biological data using linear and nonlinear regression: a practical guide to curve fitting: Oxford University Press; 2004. Motulsky H, Christopoulos A. Fitting models to biological data using linear and nonlinear regression: a practical guide to curve fitting: Oxford University Press; 2004.
43.
go back to reference Patmanidis S, Charalampidis AC, Kordonis I, Strati K, Mitsis GD, Papavassilopoulos GP. Individualized growth prediction of mice skin tumors with maximum likelihood estimators. Comput Methods Prog Biomed. 2020;185:105165.CrossRef Patmanidis S, Charalampidis AC, Kordonis I, Strati K, Mitsis GD, Papavassilopoulos GP. Individualized growth prediction of mice skin tumors with maximum likelihood estimators. Comput Methods Prog Biomed. 2020;185:105165.CrossRef
44.
go back to reference Festing MFW, Altman DG. Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J. 2002;43:244–58.CrossRef Festing MFW, Altman DG. Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J. 2002;43:244–58.CrossRef
45.
go back to reference Festing MFW. Design and statistical methods in studies using animal models of development. ILAR J. 2006;47:5–14.CrossRef Festing MFW. Design and statistical methods in studies using animal models of development. ILAR J. 2006;47:5–14.CrossRef
Metadata
Title
The initial engraftment of tumor cells is critical for the future growth pattern: a mathematical study based on simulations and animal experiments
Authors
Bertin Hoffmann
Tobias Lange
Vera Labitzky
Kristoffer Riecken
Andreas Wree
Udo Schumacher
Gero Wedemann
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2020
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-020-07015-9

Other articles of this Issue 1/2020

BMC Cancer 1/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine